CASP3 and cancer: As shown in Fig. 5e, plasma enhanced the caspase-3/7 activity by 270% to 290% (p < 0.01) in both cancer cells, while in normal cells; this level was increased by 180% to 200% (p < 0.05) when compared to an untreated control.